Whitehawk Therapeutics develops antibody drug conjugates for cancer treatment, with its candidates in early clinical trials and based in New Jersey. It last closed at $3.07 on Nov 20, down 1.60% on the day. The next earnings report for WHWK is expected around Thu, Mar 11, 2027. For the quarter ended Sep 2026, WHWK reported EPS of -$0.23 on revenue of $0. Over its last 8 reports the stock moved an average of 5.3% the session after earnings. Over the last 12 months WHWK insiders bought $0 of stock on the open market and sold $2.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is WHWK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold WHWK.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on WHWKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
WHWK · as of the Nov 20 close · updated each morning
Downtrend
The stock is 3% below its 20 day and 11% below its 50 day average. It is 26% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 44). The nearest support is the Pivot at $3.06, and the nearest resistance the Pivot R1 at $3.15.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 6.7%/day
Key levels
$5.5052 week high+79.2%
$3.86200 day average+25.7%
$3.85100 day average+25.4%
$3.4150 day average+11.1%
$3.37Swing high (Oct 22)+9.8%
$3.1520 day average+2.6%
$3.15Pivot R1+2.6%
$3.07Last close
$3.06Pivot−0.3%
$2.97Pivot S1−3.3%
$2.91Swing low (Nov 5)−5.2%
$1.9752 week low−35.8%
Indicators
RSI (14)
43.65
Middle of its range
Neutral
MACD
-0.09
Above its signal line
Bullish
Stochastic
41.4
Middle of its range
Neutral
ADX (14)
18.5
No clear trend
Williams %R
-66.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-75.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.9%
Change over 10 sessions
Bearish
ATR (14)
$0.21
Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 16.7%/day
Key levels
$5.5052 week high+79.2%
$3.86200 day average+25.7%
$3.85100 day average+25.4%
$3.4150 day average+11.1%
$3.37Swing high (Oct 22)+9.8%
$3.1520 day average+2.6%
$3.15Pivot R1+2.6%
$3.07Last close
$3.06Pivot−0.3%
$2.97Pivot S1−3.3%
$2.91Swing low (Nov 5)−5.2%
$1.9752 week low−35.8%
Indicators
RSI (14)
39.59
Weak, oversold below 30
Neutral
MACD
-0.20
Below its signal line
Bearish
Stochastic
10.5
Near the bottom of its range
Oversold
ADX (14)
28.7
Trending down
Williams %R
-90.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-108.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.3%
Change over 10 sessions
Bearish
ATR (14)
$0.51
Typical daily range, 16.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Below
What happened before, for WHWK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how WHWK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow WHWK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for WHWKHow many large options trades hit WHWK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in WHWK in the last 90 days.
From SEC Form 4 filings by WHWK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WHWK is in one of them and how their past WHWK trades turned out.
Whitehawk Therapeutics is a drug developer based in Morristown, New Jersey, focused on cancer treatments. It is developing antibody drug conjugates, a type of treatment designed to deliver a cell-killing drug directly to tumor cells. Its product candidates are in early clinical trials for solid tumors such as lung, ovarian and endometrial cancers. The company's intended customers are cancer patients and the medical providers who treat them.